5 Defensive Healthcare Dividend Stocks To Buy

3. Pfizer Inc. (NYSE:PFE)

Dividend Yield as of December 12: 3.17%

Pfizer Inc. (NYSE:PFE) is a multinational pharmaceutical and biotech company. It reported a strong cash position in its recently-announced Q3 report. The company generated revenue of $22.6 billion, which beat Street estimates by $1.5 billion. It also paid $6.7 billion to shareholders in dividends, which makes it one of the best dividend stocks on our list.

Pfizer Inc. (NYSE:PFE) holds a 12-year streak of consistent dividend growth. The company offers a quarterly dividend of $0.44 per share and has a dividend yield of 3.17%, as of December 12.

Pfizer Inc. (NYSE:PFE) was a part of 77 hedge fund portfolios in Q3 2022, up from 70 in the previous quarter, as per Insider Monkey’s database. The collective value of stakes owned by these hedge funds is over $2.4 billion. Among these hedge funds, AQR Capital Management was the company’s leading stakeholder in Q3.

Diamond Hill Capital mentioned Pfizer Inc. (NYSE:PFE) in its Q3 2022 investor letter. Here is what the firm has to say:

“Also among our bottom contributors were health care products manufacturer Abbott Labs, global pharmaceutical company Pfizer Inc. (NYSE:PFE), media and technology giant Alphabet, and insurance company American International Group (AIG). Although Pfizer continues to report strong performance of its core drugs, sales of its COVID vaccine and treatment have likely peaked and sales are expected to decline going forward. We remain optimistic about the company long term as we believe management is taking the company in the right direction, focusing R&D, and making strategic acquisitions with profits generated from COVID vaccine sales.”